Dexmedetomidine versus dexamethasone as intrathecal adjuvants for tibiofibular fracture fixation under spinal anaesthesia: a prospective randomised double-blind study
DOI:
https://doi.org/10.18203/2349-2902.isj20262449Keywords:
Dexmedetomidine, Dexamethasone, Spinal anaesthesia, Tibiofibular fracture, Postoperative analgesia, Intrathecal adjuvantAbstract
Background: Postoperative pain following tibiofibular fracture fixation may outlast the analgesic duration of hyperbaric bupivacaine used for spinal anaesthesia. Intrathecal adjuvants such as dexmedetomidine and dexamethasone have been used to improve block characteristics and prolong postoperative analgesia. To compare the analgesic efficacy and safety of intrathecal dexmedetomidine and dexamethasone as adjuvants to hyperbaric bupivacaine in adults undergoing spinal anaesthesia for tibiofibular fracture fixation.
Methods: In this prospective randomised double-blind trial, 68 ASA I–II patients scheduled for unilateral tibiofibular fracture fixation were randomised to receive 15 mg hyperbaric bupivacaine with either 5 μg dexmedetomidine (BDM, n=34) or 4 mg dexamethasone (BDA, n=34). The primary outcome was duration of analgesia, defined as the interval between onset of sensory block and a Numerical Rating Scale pain score >3. Secondary outcomes included onset of sensory and motor block, postoperative pain scores, adverse events, and patient satisfaction.
Results: Baseline characteristics were comparable between groups. Compared with dexamethasone, dexmedetomidine produced a faster onset of sensory block (3.0±0.82 vs 3.8±0.9 min; p=0.001) and motor block (4.1±0.9 vs 5.0±1.1 min; p=0.001), and significantly prolonged analgesia (328.6±28.1 vs 263.0±26.1 min; p<0.001). Pain scores at 4 hours were lower and patient satisfaction was higher in the dexmedetomidine group (both p<0.001). However, hypotension occurred more frequently with dexmedetomidine (29.4% vs 2.9%; p=0.003).
Conclusion: Intrathecal dexmedetomidine provided superior block characteristics, longer postoperative analgesia, lower pain scores, and greater patient satisfaction than intrathecal dexamethasone, although these benefits were accompanied by an increased incidence of intraoperative hypotension.
References
Salaudeen GO, Afuwape OO, Eyelade OR, Olapade-Olaopa EO. Effectiveness of postoperative analgesia in the management of acute pain in day-case surgeries. Ann Afr Med. 2018;17:140–4.
Woldehaimanot TE, Eshetie TC, Kerie MW. Postoperative pain management among surgically treated patients in an Ethiopian hospital. PLoS ONE. 2014;9:102835.
Adegboye BM, Kadir, DM, Josiah C. Anaesthesia for orthopaedic surgeries in two tertiary institutions in North Central Nigeria. J Orthop Trauma Surg Rel Res. 2018;13:13–6.
Haque M, Aleem M, Haque F, Siddique A, Afrose R. Efficacy of 0.5% Hyperbaric bupivacaine with dexamethasone versus 0.5% hyperbaric bupivacaine alone in spinal anaesthesia for patient undergoing lower abdominal urological and lower limb. Orthoped Surg. 2018;27:375–81.
Swain A, Nag DS, Sahu S, Samaddar DP. Adjuvants to local anesthetics: Current understanding and future trends. World J Clin Cases. 2017;5:307–23.
Luo J, Min S. Postoperative pain management in the postanesthesia care unit: An update. J Pain Res. 2017;10:2687–98.
Manjiani D, Paul DB, Kunnumpurath S, Kaye AD, Vadivelu N. Availability and utilization of opioids for pain management: Global Issues. Ochsner J. 2014;14:208–15.
Rawal N. Current issues in postoperative pain management. Eur J Anaesthesiol. 2016;33:160–71.
Edinoff AN, Houk GM, Patil S, Bangalore Siddaiah H, Kaye AJ, Iyengar PS, et al. Adjuvant drugs for peripheral nerve blocks: The role of alpha-2 agonists, dexamethasone, midazolam, and non-steroidal anti-inflammatory drugs. Anesth Pain Med. 2021;11:1–10.
Halder S, Das A, Mandal D, Chandra M, Ray S, Biswas MR, et al. Effect of different doses of dexmedetomidine as adjuvant in bupivacaine -induced subarachnoid block for traumatized lower limb orthopaedic surgery: A prospective, double-blinded and randomized controlled study. J Clin Diagnostic Res. 2014;8:01–6.
Mahendru V, Tewari A, Katyal S, Grewal A, Singh MR, Katyal R. A comparison of intrathecal dexmedetomidine, clonidine, and fentanyl as adjuvants to hyperbaric bupivacaine for lower limb surgery: A double blind controlled study. J Anaesthesiol Clin Pharmacol. 2013;29:496–502.
Dutta S, Kumar Gupta L, Sharma V. Evaluation of efficacy of dexamethasone as an adjuvant to bupivacaine for spinal anesthesia in abdominal surgery: an institutional study. Int J Med Res Prof. 2017;3:419–22.
Omoke NI, Ekumankama FO. Incidence and pattern of extremity fractures seen in accident and emergency department of a Nigerian teaching hospital. Niger J Surg. 2020;26:28-34.
Paramasivan A, Lopez-Olivo MA, Foong TW, Tan YW, Yap APA. Intrathecal dexmedetomidine and postoperative pain: A systematic review and meta-analysis of randomized controlled trials. Eur J Pain. 2020;24:1215–27.
Ashoor TM, Hussien NS, Anis SG, Esmat IM. Dexamethasone blunts postspinal hypotension in geriatric patients undergoing orthopedic surgery: a double blind, placebo-controlled study. BMC Anesthesiol. 2021;21:1–9. 30772; PubMed Central PMCID: PMC7798187.
Elzayyat N, Ahmed Nagy H, Girgis K. Comparing the effect of adding dexmedetomidine versus dexamethasone on prolonging the duration of intrathecal bupivacaine in lower abdominal operations. Ain-Shams J Anesthesiol. 2014;7:388–92.
Kirkwood BR, Sterne JAC. Essential Medical statistics. Blackwell Science. 2nd edn. Oxford OX4 2DDQ, UK: Blackwell Publishing Ltd; 2003: 413–512.
Panigrahi R, Roy R, Prasad A, Mahapatra AK, Priyadarshi A, Palo N. High dose dexamethasone offers better postoperative analgesia than dexmedetomidine when added to intra articular ropivacaine following knee arthroscopic surgery. Anaesth, Pain & Intensive Care. 2016;20:273–7.
Zhang Y, Shan Z, Kuang L, Xu Y, Xiu H, Wen J, et al. The effect of different doses of intrathecal dexmedetomidine on spinal anesthesia: a meta analysis. Int J Clin Exp Med. 2016;9:18860–7.
Masuki S, Dinenno FA, Joyner MJ, Eisenach JH. Selective α2-adrenergic properties of dexmedetomidine over clonidine in the human forearm. J Appl Physiol. 2005;99:587–92.
Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother. 2007;41:245–52.
Elshahawy ME, Taman HI, Elawady MS, Farid AM. Comparison of dexmedetomidine versus dexamethasone as adjuvants to intrathecal bupivacaine in emergency orthopedic lower limb operations. Egypt J Hosp Med. 2022;88:2382–7.
Abd El-Hamed Hassan A, Abd-Allah Al-Kumity A, El-Deen Mahmoud Sayed Ahmed A, Abd El-Latif Shabaiek I. Clinical comparative study between intrathecal dexmedetomidine and dexamethasone on prolonging the duration of intrathecal blockade in lower limb orthopedic surgery. Al-Azhar Assiut Med J. 2021;50:1467–78.
Ismaiel M, Safty O, El-Agamy A, Mohamed O, Ali M. A comparative study between dexmedetomidine and dexamethasone as an intrathecal adjuvant for prevention of perioperative shivering in cesarean section. Ain-Shams Journal of Anesthesiology. 2020;12:53.
Nair AS, Afshan G, Kubricht V, Chetty S, Jagannathan B. Factors influencing patient satisfaction in postoperative pain management: A systematic review and meta-analysis. Indian J Anaesth. 2025;69:1260–73.
El-Attar A, Aleem MA, Beltagy R, Ahmed W. A comparative study of intrathecal dexmedetomidine and fentanyl as additives to bupivacaine. Res Opin Anesth Intensive Care. 2015;2:43–9.
Downloads
Published
How to Cite
Issue
Section
